China’s centralised medicine procurement programme launched in 2019 has helped to bring down prices of many drugs. Photo: Shutterstock
China’s centralised medicine procurement programme launched in 2019 has helped to bring down prices of many drugs. Photo: Shutterstock

First company banned from China’s centralised drugs procurement programme after it fails to honour contract

  • Authorities to tighten the criteria for pharmaceutical companies that want to take part in the centralised drugs procurement programme
  • North China Pharmaceutical is the first drug maker in the programme to renege on its contract

China’s centralised medicine procurement programme launched in 2019 has helped to bring down prices of many drugs. Photo: Shutterstock
China’s centralised medicine procurement programme launched in 2019 has helped to bring down prices of many drugs. Photo: Shutterstock
READ FULL ARTICLE